Abstract
Background:
Evidence regarding the relationship of n-3 fatty acids (FA) to type 2 diabetes and metabolic syndrome components (MetS) is inconsistent.
Objective:
To examine associations of adipose tissue n-3 FA with MetS.
Design:
We studied 1611 participants without prior history of diabetes or heart disease who were participants in a population-based case–control study of diet and heart disease (The Costa Rica Heart Study). We calculated prevalence ratios (PR) and 95% confidence intervals (CI) for MetS by quartile of n-3 FA in adipose tissue derived mainly from plants (α-Linolenic acid (ALA)), fish (eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)) or metabolism (docosapentaenoic acid (DPA), as well as the EPA:ALA ratio, a surrogate marker of delta-6 desaturase activity).
Results:
N-3 FA levels in adipose tissue were associated with MetS prevalence in opposite directions. The PR (95% CI) for the highest compared with the lowest quartile adjusted for age, sex, body mass index (BMI), residence, lifestyle, diet and other FAs were 0.60 (0.44, 0.81) for ALA, 1.43 (1.12, 1.82) for EPA, 1.63 (1.22, 2.18) for DPA and 1.47 (1.14, 1.88) for EPA:ALA, all P for trend <0.05. Although these associations were no longer significant (except DPA) after adjustment for BMI, ALA and DPA were associated with lower glucose and higher triglyceride levels, P<0.05 (respectively).
Conclusions:
These results suggest that ALA could exert a modest protective benefit, whereas EPA and DHA are not implicated in MetS. The positive associations for DPA and MetS could reflect higher delta-6 desaturase activity caused by increased adiposity.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
International Diabetes Foundation. IDF Diabetes Atlas, 6th edn. Available from http://www.idf.org/diabetesatlas (cited 6 December 2012)..
Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C . American Heart A Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433–438.
Balk E, Chung M, Lichtenstein A, Chew P, Kupelnick B, Lawrence A et al. Effects of Omega-3 Fatty Acids on Cardiovascular Risk Factors and Intermediate Markers of Cardiovascular Disease. Summary, Evidence Report/Technology Assessment: Number 93. AHRQ Publication Number 04-E010-1. Agency for Healthcare Research and Quality: Rockville, MD, 2004. http://www.ahrq.gov/clinic/epcsums/o3cardrisksum.htm.
Zhang G, Sun Q, Hu FB, Ye X, Yu Z, Zong G et al. Erythrocyte n-3 fatty acids and metabolic syndrome in middle-aged and older Chinese. J Clin Endocrinol Metab 2012; 97: E973–E977.
Huang T, Bhulaidok S, Cai Z, Xu T, Xu F, Wahlqvist ML et al. Plasma phospholipids n-3 polyunsaturated fatty acid is associated with metabolic syndrome. Mol Nutr Food Res 2010; 54: 1628–1635.
Lai YH, Petrone AB, Pankow JS, Arnett DK, North KE, Ellison RC et al. Association of dietary omega-3 fatty acids with prevalence of metabolic syndrome: The National Heart, Lung, and Blood Institute Family Heart Study. Clin Nutr 2013; 32: 966–969.
Baik I, Abbott RD, Curb JD, Shin C . Intake of fish and n-3 fatty acids and future risk of metabolic syndrome. J Am Diet Assoc 2010; 110: 1018–1026.
Wu JH, Micha R, Imamura F, Pan A, Biggs ML, Ajaz O et al. Omega-3 fatty acids and incident type 2 diabetes: a systematic review and meta-analysis. Br J Nutr 2012; 107 (Suppl 2): S214–S227.
Petrova S, Dimitrov P, Willett WC, Campos H . The global availability of n-3 fatty acids. Public Health Nutr 2011; 14: 1157–1164.
Campos H, Baylin A, Willett WC . Alpha-linolenic acid and risk of nonfatal acute myocardial infarction. Circulation 2008; 118: 339–345.
Kabagambe EK, Baylin A, Ascherio A, Campos H . The type of oil used for cooking is associated with the risk of nonfatal acute myocardial infarction in costa rica. J Nutr 2005; 135: 2674–2679.
Expert Panel on Detection ETreatment of High Blood Cholesterol in A. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486–2497.
Baylin A, Kabagambe EK, Siles X, Campos H . Adipose tissue biomarkers of fatty acid intake. Am J Clin Nutr 2002; 76: 750–757.
Dayton S, Hashimoto S, Dixon W, Pearce ML . Composition of lipids in human serum and adipose tissue during prolonged feeding of a diet high in unsaturated fat. J Lipid Res 1966; 7: 103–111.
Katan MB, Deslypere JP, van Birgelen AP, Penders M, Zegwaard M . Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18-month controlled study. J Lipid Res 1997; 38: 2012–2022.
Lillington JM, Trafford DJ, Makin HL . A rapid and simple method for the esterification of fatty acids and steroid carboxylic acids prior to gas-liquid chromatography. Clin Chim Acta 1981; 111: 91–98.
Baylin A, Kim MK, Donovan-Palmer A, Siles X, Dougherty L, Tocco P et al. Fasting whole blood as a biomarker of essential fatty acid intake in epidemiologic studies: comparison with adipose tissue and plasma. Am J Epidemiol 2005; 162: 373–381.
Sprecher H, Luthria DL, Mohammed BS, Baykousheva SP . Reevaluation of the pathways for the biosynthesis of polyunsaturated fatty acids. J Lipid Res 1995; 36: 2471–2477.
Sprecher H . Metabolism of highly unsaturated n-3 and n-6 fatty acids. Biochim Biophys Acta 2000; 1486: 219–231.
Ailhaud G, Massiera F, Weill P, Legrand P, Alessandri JM, Guesnet P . Temporal changes in dietary fats: role of n-6 polyunsaturated fatty acids in excessive adipose tissue development and relationship to obesity. Prog Lipid Res 2006; 45: 203–236.
Goyens PL, Mensink RP . The dietary alpha-linolenic acid to linoleic acid ratio does not affect the serum lipoprotein profile in humans. J Nutr 2005; 135: 2799–2804.
Williams ES, Baylin A, Campos H . Adipose tissue arachidonic acid and the metabolic syndrome in Costa Rican adults. Clin Nutr 2007; 26: 474–482.
Spiegelman D, Hertzmark E . Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol 2005; 162: 199–200.
Mattei J, Malik V, Hu FB, Campos H . Substituting homemade fruit juice for sugar-sweetened beverages is associated with lower odds of metabolic syndrome among Hispanic adults. J Nutr 2012; 142: 1081–1087.
Mattei J, Hu FB, Campos H . A higher ratio of beans to white rice is associated with lower cardiometabolic risk factors in Costa Rican adults. Am J Clin Nutr 2011; 94: 869–876.
White H . A Heteroskedasticity-Consistent Covariance Matrix Estimator and a Direct Test for Heteroskedasticity. Econometrica (pre-1986) 1980; 48: 817.
Carpentier YA, Portois L, Malaisse WJ . n-3 fatty acids and the metabolic syndrome. Am J Clin Nutr 2006; 83 (Suppl 6): 1499S–1504S.
Iggman D, Arnlov J, Vessby B, Cederholm T, Sjogren P, Riserus U . Adipose tissue fatty acids and insulin sensitivity in elderly men. Diabetologia 2010; 53: 850–857.
Brunner EJ, Jones PJ, Friel S, Bartley M . Fish, human health and marine ecosystem health: policies in collision. Int J Epidemiol 2009; 38: 93–100.
Ruiz-Narvaez EA, Bare L, Arellano A, Catanese J, Campos H . West African and Amerindian ancestry and risk of myocardial infarction and metabolic syndrome in the Central Valley population of Costa Rica. Hum Genet 2010; 127: 629–638.
Ebbesson SO, Tejero ME, Nobmann ED, Lopez-Alvarenga JC, Ebbesson L, Romenesko T et al. Fatty acid consumption and metabolic syndrome components: the GOCADAN study. J Cardiometab Syndr 2007; 2: 244–249.
Sun Q, Ma J, Campos H, Hankinson SE, Hu FB . Comparison between plasma and erythrocyte fatty acid content as biomarkers of fatty acid intake in US women. Am J Clin Nutr 2007; 86: 74–81.
Warensjo E, Rosell M, Hellenius ML, Vessby B, De Faire U, Riserus U . Associations between estimated fatty acid desaturase activities in serum lipids and adipose tissue in humans: links to obesity and insulin resistance. Lipids Health Dis 2009; 8: 37.
Warensjo E, Sundstrom J, Lind L, Vessby B . Factor analysis of fatty acids in serum lipids as a measure of dietary fat quality in relation to the metabolic syndrome in men. Am J Clin Nutr 2006; 84: 442–448.
Fevre C, Bellenger S, Pierre AS, Minville M, Bellenger J, Gresti J et al. The metabolic cascade leading to eicosanoid precursors—desaturases, elongases, and phospholipases A2—is altered in Zucker fatty rats. Biochim Biophys Acta 2011; 1811: 409–417.
Wang Y, Botolin D, Xu J, Christian B, Mitchell E, Jayaprakasam B et al. Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity. J Lipid Res 2006; 47: 2028–2041.
Sargent JR . Fish oils and human diet. Br J Nutr 1997; 78 (Suppl 1): S5–S13.
Baylin A, Siles X, Donovan-Palmer A, Fernandez X, Campos H . Fatty acid composition of Costa Rican foods including trans fatty acid content. J Food Compost Anal 2007; 20: 182–192.
Emken EA, Adlof RO, Duval SM, Nelson GJ . Effect of dietary docosahexaenoic acid on desaturation and uptake in vivo of isotope-labeled oleic, linoleic, and linolenic acids by male subjects. Lipids 1999; 34: 785–791.
Patel PS, Sharp SJ, Jansen E, Luben RN, Khaw KT, Wareham NJ et al. Fatty acids measured in plasma and erythrocyte-membrane phospholipids and derived by food-frequency questionnaire and the risk of new-onset type 2 diabetes: a pilot study in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk cohort. Am J Clin Nutr 2010; 92: 1214–1222.
Hodge AM, English DR, O'Dea K, Sinclair AJ, Makrides M, Gibson RA et al. Plasma phospholipid and dietary fatty acids as predictors of type 2 diabetes: interpreting the role of linoleic acid. Am J Clin Nutr 2007; 86: 189–197.
Krachler B, Norberg M, Eriksson JW, Hallmans G, Johansson I, Vessby B et al. Fatty acid profile of the erythrocyte membrane preceding development of Type 2 diabetes mellitus. Nutr Metab Cardiovasc Dis 2008; 18: 503–510.
Kroger J, Zietemann V, Enzenbach C, Weikert C, Jansen EH, Doring F et al. Erythrocyte membrane phospholipid fatty acids, desaturase activity, and dietary fatty acids in relation to risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Am J Clin Nutr 2011; 93: 127–142.
Acknowledgements
Supported by the National Institutes of Health HL49086 and HL60692.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on European Journal of Clinical Nutrition website
Supplementary information
Rights and permissions
About this article
Cite this article
Cespedes, E., Baylin, A. & Campos, H. Adipose tissue n-3 fatty acids and metabolic syndrome. Eur J Clin Nutr 69, 114–120 (2015). https://doi.org/10.1038/ejcn.2014.150
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ejcn.2014.150
This article is cited by
-
Red meat consumption and metabolic syndrome in the Costa Rica Heart Study
European Journal of Nutrition (2020)